GlassScriptPhysician profile
John C Friel
NPI 1952333700
$12,819.01
in general payments reported to CMS, 2019-2025
13 companies · $7,217 in 2025
The $7,217 reported for 2025 was more than what 91% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,737 · 2020: $1,009 · 2021: $18.64 · 2022: $1,824 · 2024: $14.00 · 2025: $7,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,720 · Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,719.53 |
| Food and Beverage | $511.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,473.67 | 2019-2025 | |
| Stryker Corporation | $1,053.88 | 2022-2025 | 1788 |
| Covidien LP | $975.00 | 2020 | |
| Ethicon US, LLC | $78.91 | 2022-2025 | Enseal X1, Ethicon, Vistaseal |
| Acell, INC. | $44.92 | 2019 | |
| Abbvie INC. | $34.11 | 2025 | |
| Lemaitre Vascular, INC. | $34.10 | 2025 | Artegraft Vascular Graft |
| Tei Biosciences INC | $26.86 | 2019 | |
| Pfizer INC. | $25.56 | 2019 | |
| Polynovo North America LLC | $19.54 | 2025 | Novosorb Btm |
| Tela Bio, INC. | $18.64 | 2021 | |
| Coopersurgical, INC. | $17.00 | 2020 | |
| Kci USA, INC. | $16.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Friel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.